news

Select Biosciences Second Annual Organ-on-a-Chip World Congress and 3D-Culture, July 7-8, 2016, Boston, USA.

0
SHARES

Posted: 18 February 2016 | Select Biosciences | No comments yet

Select Biosciences is organizing its 2nd Annual World Congress focusing on Organs-on-Chips—an extremely important and cutting-edge field of important in basic research as well as pharmaceutical discovery and development…

Select Biosciences Second Annual Organ-on-a-Chip World Congress and 3D-Culture, July 7-8, 2016, Boston, USA.

Select Biosciences is organizing its 2nd Annual World Congress focusing on Organs-on-Chips—an extremely important and cutting-edge field of important in basic research as well as pharmaceutical discovery and development.

Key Opinion Leaders (KOLs) in this field are keynoting the conference—here is the list:

  • George Truskey, R. Eugene and Susie E. Goodson Professor of Biomedical Engineering, Duke University
  • Geraldine A. Hamilton, President & CSO, Emulate; Formerly the Lead Senior Staff Scientist, Wyss Institute for Biologically Inspired Engineering, Harvard University
  • James Hickman, Professor, University of Central Florida
  • Kristin Fabre, Scientific Program Manager, NIH National Center for Advancing Translational Science (NCATS)
  • Linda Griffith, Professor of Biological and Mechanical Engineering, Massachusetts Institute of Technology (MIT)
  • Martin Yarmush, Director, Center for Engineering in Medicine, Massachusetts General Hospital (MGH)
  • Michael Shuler, Samuel B. Eckert Professor of Engineering, Cornell University
  • Nancy Allbritton, Professor and Chair, University of North Carolina
  • Reyk Horland, Vice President, TissUse GmbH
  • Roger Kamm, Professor, Massachusetts Institute of Technology (MIT)
  • Wei Sun, Professor, Tsinghua University and Albert Soffa Chair Professor of Mechanical Engineering, Drexel University

For more information please visit

http://selectbiosciences.com/conferences/index.aspx?conf=OOACWC2016

For more details, please contact:

Jeff Fan
SELECTBIO US
Telephone: +1-510-857-4865
Jeff@selectbio.us

Drug Target Review has just announced the launch of its NEW and EXCLUSIVE report examining the evolution of AI and informatics in drug discovery and development. 

In this 63 page in-depth report, experts and researchers explore the key benefits of AI and informatics processes, reveal where the challenges lie for the implementation of AI and how they see the use of these technologies streamlining workflows in the future. 

Also featured are exclusive interviews with leading scientists from AstraZeneca, Auransa, PolarisQB and Chalmers University of Technology.

FREE DOWNLOAD HERE

Related topics

Related organisations